tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Ratios

Compare
2,264 Followers

Catalyst Pharma Ratios

CPRX's free cash flow for Q4 2024 was $0.85. For the 2024 fiscal year, CPRX's free cash flow was decreased by $ and operating cash flow was $0.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.17 2.88 5.57 7.76 7.00
Quick Ratio
5.01 2.68 5.45 7.47 6.79
Cash Ratio
4.29 1.81 5.18 6.34 5.72
Solvency Ratio
1.32 1.27 1.12 1.29 3.33
Operating Cash Flow Ratio
1.19 1.89 2.02 2.23 1.98
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 499.83M$ 137.10M$ 245.59M$ 179.15M$ 136.49M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.01 0.02 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 0.01 0.02 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 0.01 0.02 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.01 0.02 0.00
Financial Leverage Ratio
1.17 1.21 1.25 1.15 1.13
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 0.00
Interest Debt Per Share
0.02 0.03 0.04 0.04 <0.01
Net Debt to EBITDA
-2.64 -1.12 -2.89 -3.20 -3.15
Profitability Margins
Gross Profit Margin
86.00%78.77%83.94%84.46%85.69%
EBIT Margin
39.68%21.80%48.89%37.40%35.18%
EBITDA Margin
39.68%30.06%47.54%37.20%34.69%
Operating Profit Margin
39.68%21.80%47.54%37.20%34.69%
Pretax Profit Margin
43.98%23.73%48.89%37.40%35.18%
Net Profit Margin
33.33%17.93%38.79%28.03%62.97%
Continuous Operations Profit Margin
33.33%17.93%38.79%28.03%62.97%
Net Income Per EBT
75.78%75.56%79.34%74.97%179.00%
EBT Per EBIT
110.83%108.87%102.83%100.54%101.42%
Return on Assets (ROA)
19.25%15.19%22.12%16.60%38.98%
Return on Equity (ROE)
22.52%18.41%27.65%19.09%44.21%
Return on Capital Employed (ROCE)
26.70%22.03%32.02%24.86%24.35%
Return on Invested Capital (ROIC)
20.24%16.63%25.38%18.61%43.59%
Return on Tangible Assets
23.59%25.87%24.21%16.60%38.98%
Earnings Yield
6.63%4.00%4.32%5.64%21.69%
Efficiency Ratios
Receivables Turnover
7.51 7.44 20.52 21.28 19.89
Payables Turnover
4.15 5.71 8.65 7.91 4.00
Inventory Turnover
3.52 5.40 5.05 2.78 3.66
Fixed Asset Turnover
137.20 107.54 59.22 35.42 917.36
Asset Turnover
0.58 0.85 0.57 0.59 0.62
Working Capital Turnover Ratio
1.52 1.96 0.96 0.88 1.06
Cash Conversion Cycle
64.23 52.72 47.82 102.25 26.81
Days of Sales Outstanding
48.60 49.05 17.79 17.15 18.35
Days of Inventory Outstanding
103.60 67.55 72.22 131.26 99.62
Days of Payables Outstanding
87.97 63.88 42.19 46.17 91.17
Operating Cycle
152.20 116.60 90.01 148.42 117.98
Cash Flow Ratios
Operating Cash Flow Per Share
1.21 1.35 1.12 0.58 0.44
Free Cash Flow Per Share
1.21 -0.52 1.12 0.57 0.43
CapEx Per Share
<0.01 1.87 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 -0.38 1.00 0.98 1.00
Dividend Paid and CapEx Coverage Ratio
621.65 0.72 4.00K 59.13 3.95K
Capital Expenditure Coverage Ratio
621.65 0.72 4.00K 59.13 3.95K
Operating Cash Flow Coverage Ratio
51.54 40.37 29.80 15.50 1.57K
Operating Cash Flow to Sales Ratio
0.29 0.36 0.54 0.43 0.38
Free Cash Flow Yield
5.80%-3.07%6.03%8.48%13.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.08 25.02 23.14 17.73 4.61
Price-to-Sales (P/S) Ratio
5.03 4.49 8.98 4.97 2.90
Price-to-Book (P/B) Ratio
3.40 4.61 6.40 3.38 2.04
Price-to-Free Cash Flow (P/FCF) Ratio
17.24 -32.53 16.57 11.79 7.68
Price-to-Operating Cash Flow Ratio
17.22 12.44 16.57 11.59 7.68
Price-to-Earnings Growth (PEG) Ratio
0.14 -1.54 0.21 -0.38 0.03
Price-to-Fair Value
3.40 4.61 6.40 3.38 2.04
Enterprise Value Multiple
10.03 13.81 15.99 10.16 5.22
EV to EBITDA
10.03 13.81 15.99 10.16 5.22
EV to Sales
3.98 4.15 7.60 3.78 1.81
EV to Free Cash Flow
13.65 -30.09 14.03 8.97 4.79
EV to Operating Cash Flow
13.63 11.51 14.03 8.82 4.79
Tangible Book Value Per Share
4.82 1.82 2.59 2.00 1.64
Shareholders’ Equity Per Share
6.14 3.65 2.91 2.00 1.64
Tax and Other Ratios
Effective Tax Rate
0.24 0.24 0.21 0.25 -0.79
Revenue Per Share
4.15 3.75 2.07 1.36 1.15
Net Income Per Share
1.38 0.67 0.80 0.38 0.72
Tax Burden
0.76 0.76 0.79 0.75 1.79
Interest Burden
1.11 1.09 1.00 1.00 1.00
Research & Development to Revenue
0.03 0.23 0.09 0.12 0.14
SG&A to Revenue
0.14 0.12 0.13 0.17 0.17
Stock-Based Compensation to Revenue
0.05 0.04 0.04 0.04 0.05
Income Quality
0.88 2.01 1.40 1.53 0.60
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis